Skip to main content

Cubist Pharmaceuticals Inc (NASDAQ:CBST) Investor Files Lawsuit In Effort To Halt The Proposed Acquisition

  • If you purchased shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST) and currently hold any of those NASDAQ:CBST shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

December 19, 2014 (Shareholders Foundation) - An investor, who currently holds shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST), filed a lawsuit in effort to halt the proposed takeover of Cubist Pharmaceuticals Inc by Merck for $102 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:CBST stockholders by agreeing to sell Cubist Pharma...



You must register (for free) or login to view the entire case.